Literature DB >> 3896285

Calcium channel blockers--are they diuretics?

M A Young, R D Watson, T J Stallard, W A Littler.   

Abstract

Seven untreated patients with essential hypertension but without target organ damage were admitted to hospital. Urine was collected the following day from 08.00 to 13.00 h, 13.00 to 18.00 h, and 18.00 to 08.00 h. The protocol was repeated the next day following 30 mg oral nicardipine. Intra-arterial blood pressure (IABP), plasma volume, and plasma renin activity (PRA) also were measured daily. Following the single-dose study, the patients were treated as outpatients and received oral nicardipine 20, 30, or 40 mg four times daily. They were readmitted 2 months later for further study, at which time the protocol was repeated. Urine output between 08.00 and 13.00 h significantly increased after the single- and multiple-dose studies. Following the single-dose study, this diuresis was associated with a natriuresis. Urine output increased over the 24 h following multiple-dose treatment, but this increase was not statistically significant. During the multiple-dose 24 h study, there was an increase in urinary potassium (P less than 0.05). Mean IABP was reduced significantly after the single- and multiple-dose studies (P less than 0.02 and less than 0.05, respectively). During the study, there were no significant changes in plasma volume, weight, or plasma renin activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3896285      PMCID: PMC1400783          DOI: 10.1111/j.1365-2125.1985.tb05149.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

1.  Measurement of concentrations of angiotensin I in human blood by radioimmunoassay.

Authors:  M A Waite
Journal:  Clin Sci       Date:  1973-07       Impact factor: 6.124

2.  [Effect of BAY a 1040 on renal function in hypertension].

Authors:  K Klütsch; P Schmidt; J Grosswendt
Journal:  Arzneimittelforschung       Date:  1972-02

3.  The effect of nifedipine on arterial pressure and reflex cardiac control.

Authors:  R A McLeay; T J Stallard; R D Watson; W A Littler
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

4.  Renal tubular site of action of felodipine.

Authors:  G F Dibona; L L Sawin
Journal:  J Pharmacol Exp Ther       Date:  1984-02       Impact factor: 4.030

5.  The effect of a new calcium channel blocker nicardipine on 24-hour ambulatory blood pressure and the pressor response to isometric and dynamic exercise.

Authors:  R I Jones; R S Hornung; T Sonecha; E B Raftery
Journal:  J Hypertens       Date:  1983-06       Impact factor: 4.844

6.  Antihypertensive and renal effects of nicardipine.

Authors:  B A van Schaik; A E van Nistelrooy; G G Geyskes
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

7.  Comparison of cardiovascular, renal, and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects.

Authors:  G Leonetti; C Cuspidi; L Sampieri; L Terzoli; A Zanchetti
Journal:  J Cardiovasc Pharmacol       Date:  1982       Impact factor: 3.105

8.  Effects of intrarenal infusion of calcium entry blockers in anesthetized dogs.

Authors:  J R Dietz; J O Davis; R H Freeman; D Villarreal; S F Echtenkamp
Journal:  Hypertension       Date:  1983 Jul-Aug       Impact factor: 10.190

  8 in total
  4 in total

1.  Antihypertensive effect of slow-release nicardipine. A placebo-controlled cross-over study.

Authors:  A Salvetti; G Cardellino; M Pesenti; A Caiazza; F Ghisoni; C Del Prato; P F Innocenti; F Ponzanelli; M Errico; M Freda
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  Aims of combination therapy--improved quality of life or better blood pressure control?

Authors:  D Maclean
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 3.  Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

4.  Calcium Antagonists Use and Its Association with Lower Urinary Tract Symptoms: A Cross-Sectional Study.

Authors:  Elsamaul S Elhebir; Jeffery D Hughes; Samantha C Hilmi
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.